Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06101914
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-10-20
Brief Title:
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
Sponsor:
Power Life Sciences Inc
Organization:
Power Life Sciences Inc
Study Overview
Official Title:
Evaluating the Occurrence of Engagement Patterns and Participation Trends Among Patients in Treatment Resistant Depression
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clinical studies with a distinct focus on treatment resistant depression play a crucial role in evaluating the safety and effectiveness of novel treatments These trials serve as instrumental means to determine whether new medications surpass conventional therapies providing substantial evidence for their broader adoption
The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group
The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None